ArticleJournal of cancer research and clinical oncology2023

Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse.

Oliver Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.